These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 27404705)

  • 21. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
    Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
    Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of coronary artery plaque composition, morphology and burden on Absorb bioresorbable vascular scaffold expansion and eccentricity - A detailed analysis with optical coherence tomography.
    Shaw E; Allahwala UK; Cockburn JA; Hansen TCE; Mazhar J; Figtree GA; Hansen PS; Bhindi R
    Int J Cardiol; 2015 Apr; 184():230-236. PubMed ID: 25723650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expansion and malapposition characteristics after bioresorbable vascular scaffold implantation.
    Brown AJ; McCormick LM; Braganza DM; Bennett MR; Hoole SP; West NE
    Catheter Cardiovasc Interv; 2014 Jul; 84(1):37-45. PubMed ID: 24403223
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac allograft vasculopathy: optical coherence guided innovative treatment options with the bioresorbable vascular scaffold: proof of concept.
    Édes IF; Hajas Á; Sax B; Bartykowszki A; Becker D; Merkely B
    Minerva Cardioangiol; 2016 Aug; 64(4):487-93. PubMed ID: 27152623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioresorbable vascular scaffolds for small vessels coronary disease: The BVS-save registry.
    Latini RA; Granata F; Ielasi A; Varricchio A; Moscarella E; Tespili M; Cortese B
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):380-7. PubMed ID: 27038332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct bioresorbable vascular scaffold implantation: Feasibility and midterm results.
    Suárez de Lezo J; Martín P; Mazuelos F; Nóvoa J; Ojeda S; Pan M; Segura J; Hernández E; Romero M; Melián F; Medina A; Suárez de Lezo J
    Catheter Cardiovasc Interv; 2016 Apr; 87(5):E173-82. PubMed ID: 26268440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical Coherence Tomography and Stent Boost Imaging Guided Bioresorbable Vascular Scaffold Overlapping for Coronary Chronic Total Occlusion Lesion.
    Li H; Rha SW; Choi CU; Oh DJ
    Yonsei Med J; 2017 Sep; 58(5):1071-1074. PubMed ID: 28792157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized Comparison of Optical Coherence Tomography Versus Angiography to Guide Bioresorbable Vascular Scaffold Implantation: The OPTICO BVS Study.
    Ueki Y; Yamaji K; Barbato E; Nef H; Brugaletta S; Alfonso F; Hill J; Cook S; Burzotta F; Karagiannis A; Windecker S; Räber L
    Cardiovasc Revasc Med; 2020 Oct; 21(10):1244-1250. PubMed ID: 32205067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the hemodynamic characteristics of Absorb BVS in a porcine coronary artery model.
    Tenekecioglu E; Torii R; Bourantas C; Abdelghani M; Cavalcante R; Sotomi Y; Crake T; Su S; Santoso T; Onuma Y; Serruys PW
    Int J Cardiol; 2017 Jan; 227():467-473. PubMed ID: 27839816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiographic and Midterm Outcomes of Bioresorbable Vascular Scaffold for Coronary Bifurcation Lesions.
    Paradies V; Vlachojannis GJ; Royaards KJ; Wassing J; van der Ent M; Smits PC
    Am J Cardiol; 2018 Dec; 122(12):2035-2042. PubMed ID: 30360886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up of coronary artery patency after implantation of bioresorbable coronary scaffolds: The emerging role of magnetic coronary artery imaging.
    Zuin M; Rigatelli G; Scaranello F; Rinuncini M; Picariello C; D'Elia K; Fejzo M; Roncon L
    Cardiovasc Revasc Med; 2017; 18(5):369-373. PubMed ID: 28254259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.
    Serruys PW; Katagiri Y; Sotomi Y; Zeng Y; Chevalier B; van der Schaaf RJ; Baumbach A; Smits P; van Mieghem NM; Bartorelli A; Barragan P; Gershlick A; Kornowski R; Macaya C; Ormiston J; Hill J; Lang IM; Egred M; Fajadet J; Lesiak M; Windecker S; Byrne RA; Räber L; van Geuns RJ; Mintz GS; Onuma Y
    J Am Coll Cardiol; 2017 Jul; 70(1):60-74. PubMed ID: 28662808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients".
    Abellas-Sequeiros RA; Ocaranza-Sanchez R; Galvão Braga C; Raposeiras-Roubin S; Lopez-Otero D; Cid-Alvarez B; Souto-Castro P; Trillo-Nouche R; Gonzalez-Juanatey JR
    Int J Cardiol; 2016 Sep; 219():264-70. PubMed ID: 27343418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine use of optical coherence tomography in bioresorbable vascular scaffold implantation: insights on technique optimization and long-term outcomes.
    Abdelaziz HK; Abuomara HZ; Ali MH; Eichhofer J; Patel B; Saad M
    Coron Artery Dis; 2019 Jun; 30(4):263-269. PubMed ID: 30883433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of frequency-domain optical coherence tomography guidance for optimal coronary stent implantation in comparison with intravascular ultrasound guidance.
    Habara M; Nasu K; Terashima M; Kaneda H; Yokota D; Ko E; Ito T; Kurita T; Tanaka N; Kimura M; Ito T; Kinoshita Y; Tsuchikane E; Asakura K; Asakura Y; Katoh O; Suzuki T
    Circ Cardiovasc Interv; 2012 Apr; 5(2):193-201. PubMed ID: 22456026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioresorbable everolimus-eluting vascular scaffold for the treatment of chronic total occlusions: CTO-ABSORB pilot study.
    Vaquerizo B; Barros A; Pujadas S; Bajo E; Estrada D; Miranda-Guardiola F; Rigla J; Jiménez M; Cinca J; Serra A
    EuroIntervention; 2015 Sep; 11(5):555-63. PubMed ID: 25499833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized trial comparing two stent sizing strategies in coronary bifurcation treatment with bioresorbable vascular scaffolds - The Absorb Bifurcation Coronary (ABC) trial.
    Rampat R; Mayo T; Hildick-Smith D; Cockburn J
    Cardiovasc Revasc Med; 2019 Jan; 20(1):43-49. PubMed ID: 30170828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioresorbable vascular scaffolds in STEMI patients: multimodality imaging comparison in mid-term perspective.
    Marchese G; Petr R; Tousek P; Widimsky P; Kocka V
    Minerva Cardioangiol; 2016 Aug; 64(4):411-8. PubMed ID: 27070202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary artery perforation after bioresorbable scaffold implantation treated with a new generation covered stent-OCT insights.
    Chen D; Gadeley R; Wang A; Jepson N
    BMC Cardiovasc Disord; 2022 Feb; 22(1):66. PubMed ID: 35196989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.